Chandan Healthcare Limited — PPTs, 22-06-2026: Investor Presentation

Chandan Healthcare closed FY26 strong, with Total Income hitting ₹280.67 Cr (+20.43% YoY), EBITDA soaring to ₹56.84 Cr (+31.02% YoY) at a 20.25% margin, and PAT growing to ₹27.06 Cr (+22.04% YoY) with a 9.64% margin. Diluted EPS stood at ₹10.76.

The company is aggressively expanding its network, launching new diagnostic centers in Mumbai, Kolkata, and Raipur in Q4 FY26. It also accelerated its exclusive Jeena Sikho partnership across Punjab, Haryana, Meerut, Lucknow, and Kota. Long-term government PPP projects in Punjab, Rohtak, and Assam are boosting advanced radiology capabilities and ensuring revenue visibility.

Chandan’s strategy focuses on pan-India network expansion, improving new center utilization, and leveraging partnerships for growth. Management is optimistic about the Indian diagnostics market, aiming to build a scalable, integrated, high-quality platform, further enhance its digital ecosystem, and maintain capital efficiency for sustainable long-term growth.